Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3423451
Max Phase: Preclinical
Molecular Formula: C16H10N2S3
Molecular Weight: 326.47
Molecule Type: Small molecule
Associated Items:
ID: ALA3423451
Max Phase: Preclinical
Molecular Formula: C16H10N2S3
Molecular Weight: 326.47
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: c1csc(-c2ccc(-c3ncncc3-c3cccs3)s2)c1
Standard InChI: InChI=1S/C16H10N2S3/c1-3-12(19-7-1)11-9-17-10-18-16(11)15-6-5-14(21-15)13-4-2-8-20-13/h1-10H
Standard InChI Key: DSBDXSJKUQYSBY-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 326.47 | Molecular Weight (Monoisotopic): 326.0006 | AlogP: 5.66 | #Rotatable Bonds: 3 |
Polar Surface Area: 25.78 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 0.95 | CX LogP: 4.71 | CX LogD: 4.71 |
Aromatic Rings: 4 | Heavy Atoms: 21 | QED Weighted: 0.49 | Np Likeness Score: -0.92 |
1. Verbitskiy EV, Cheprakova EM, Slepukhin PA, Kravchenko MA, Skornyakov SN, Rusinov GL, Chupakhin ON, Charushin VN.. (2015) Synthesis, and structure-activity relationship for C(4) and/or C(5) thienyl substituted pyrimidines, as a new family of antimycobacterial compounds., 97 [PMID:25982331] [10.1016/j.ejmech.2015.05.007] |
Source(1):